• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性肾病和先天性肾脏和尿路畸形是需要肾脏替代治疗的肾衰竭的常见原因:一项欧洲肾脏协会注册研究。

Inherited kidney disease and CAKUT are common causes of kidney failure requiring kidney replacement therapy: an ERA Registry study.

作者信息

Ortiz Alberto, Kramer Anneke, Ariceta Gema, Rodríguez Arévalo Olga L, Gjerstad Ann C, Santiuste Carmen, Trujillo-Alemán Sara, Ferraro Pietro Manuel, Methven Shona, Santamaría Rafael, Naumovic Radomir, Resic Halima, Hommel Kristine, Segelmark Mårten, Ambühl Patrice M, Sorensen Søren S, Parmentier Cyrielle, Vidal Enrico, Bakkaloglu Sevcan A, Plumb Lucy, Palsson Runolfur, Kerschbaum Julia, Ten Dam Marc A G J, Stel Vianda S, Jager Kitty J, Torra Roser

机构信息

Department of Nephrology and Hypertension, IIS-Fundacion Jimenez Diaz UAM, Madrid, Spain.

Department of Medicine, Universidad Autonoma de Madrid, Madrid, Spain.

出版信息

Nephrol Dial Transplant. 2025 Apr 28;40(5):1020-1031. doi: 10.1093/ndt/gfae240.

DOI:10.1093/ndt/gfae240
PMID:39508350
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12035533/
Abstract

BACKGROUND

Inherited kidney diseases (IKDs) and congenital anomalies of the kidney and urinary tract (CAKUT) are causes of kidney failure requiring kidney replacement therapy (KRT) that major renal registries usually amalgamate into the primary renal disease(PRD) category 'miscellaneous' or in the glomerulonephritis or pyelonephritis categories. This makes IKDs invisible (except for polycystic kidney disease) and may negatively influence the use of genetic testing, which may identify a cause for IKDs and some CAKUT.

METHODS

We re-examined the aetiology of KRT by composing a separate IKD and CAKUT PRD group using data from the European Renal Association (ERA) Registry.

RESULTS

In 2019, IKD-CAKUT was the fourth most common cause of kidney failure among incident KRT patients, accounting for 8.9% of cases [IKD 7.4% (including 5.0% autosomal dominant polycystic kidney disease), CAKUT 1.5%], behind diabetes (23.0%), hypertension (14.4%) and glomerulonephritis (10.6%). IKD-CAKUT was the most common cause of kidney failure among patients <20 years of age (41.0% of cases), but their incidence rate was highest among those ages 45-74 years (22.5 per million age-related population). Among prevalent KRT patients, IKD-CAKUT (18.5%) and glomerulonephritis (18.7%) were the two most common causes of kidney failure overall, while IKD-CAKUT was the most common cause in women (21.6%) and in patients <45 years of age (29.1%).

CONCLUSION

IKD and CAKUT are common causes of kidney failure among KRT patients. Distinct categorization of IKD and CAKUT better characterizes the epidemiology of the causes of chronic kidney disease (CKD) and highlights the importance of genetic testing in the diagnostic workup of CKD.

摘要

背景

遗传性肾病(IKDs)和先天性肾脏和尿路异常(CAKUT)是导致肾衰竭需要肾脏替代治疗(KRT)的原因,主要肾脏登记处通常将其合并到原发性肾病(PRD)类别“其他”或肾小球肾炎或肾盂肾炎类别中。这使得IKDs不被重视(除多囊肾病外),并可能对基因检测的应用产生负面影响,而基因检测可能会确定IKDs和一些CAKUT的病因。

方法

我们使用欧洲肾脏协会(ERA)登记处的数据,通过组建一个单独的IKD和CAKUT PRD组,重新审视了KRT的病因。

结果

2019年,IKD-CAKUT是新发病例KRT患者中第四大常见的肾衰竭病因,占病例的8.9%[IKD占7.4%(包括5.0%常染色体显性多囊肾病),CAKUT占1.5%],仅次于糖尿病(23.0%)、高血压(14.4%)和肾小球肾炎(10.6%)。IKD-CAKUT是20岁以下患者中最常见的肾衰竭病因(占病例的41.0%),但其发病率在45-74岁人群中最高(每百万年龄相关人群中22.5例)。在接受KRT的现患患者中,IKD-CAKUT(18.5%)和肾小球肾炎(18.7%)是总体上最常见的两个肾衰竭病因,而IKD-CAKUT是女性(21.6%)和45岁以下患者(29.1%)中最常见的病因。

结论

IKD和CAKUT是KRT患者肾衰竭的常见病因。对IKD和CAKUT进行明确分类能更好地描述慢性肾脏病(CKD)病因的流行病学特征,并突出基因检测在CKD诊断检查中的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad2/12035533/884e91a3716c/gfae240fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad2/12035533/00e064d59bae/gfae240fig1g.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad2/12035533/04c20add9093/gfae240fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad2/12035533/ec1a3a7d99cf/gfae240fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad2/12035533/20ee4c732a61/gfae240fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad2/12035533/b813b5ab8d83/gfae240fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad2/12035533/884e91a3716c/gfae240fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad2/12035533/00e064d59bae/gfae240fig1g.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad2/12035533/04c20add9093/gfae240fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad2/12035533/ec1a3a7d99cf/gfae240fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad2/12035533/20ee4c732a61/gfae240fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad2/12035533/b813b5ab8d83/gfae240fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad2/12035533/884e91a3716c/gfae240fig5.jpg

相似文献

1
Inherited kidney disease and CAKUT are common causes of kidney failure requiring kidney replacement therapy: an ERA Registry study.遗传性肾病和先天性肾脏和尿路畸形是需要肾脏替代治疗的肾衰竭的常见原因:一项欧洲肾脏协会注册研究。
Nephrol Dial Transplant. 2025 Apr 28;40(5):1020-1031. doi: 10.1093/ndt/gfae240.
2
Increasing trends in hemodialysis and living donor kidney transplantation for children and young people in the United Kingdom.英国儿童和年轻人接受血液透析及活体供肾移植的趋势呈上升态势。
Pediatr Transplant. 2022 Jun;26(4):e14232. doi: 10.1111/petr.14232. Epub 2022 Jan 24.
3
Primary causes of kidney disease and mortality in dialysis-dependent children.透析依赖儿童的肾脏疾病和死亡的主要原因。
Pediatr Nephrol. 2020 May;35(5):851-860. doi: 10.1007/s00467-019-04457-7. Epub 2020 Feb 4.
4
Timing and outcome of renal replacement therapy in patients with congenital malformations of the kidney and urinary tract.先天性肾及尿路畸形患者肾脏替代治疗的时机和结局。
Clin J Am Soc Nephrol. 2013 Jan;8(1):67-74. doi: 10.2215/CJN.03310412. Epub 2012 Oct 18.
5
Association between the clinical presentation of congenital anomalies of the kidney and urinary tract (CAKUT) and gene mutations: an analysis of 66 patients at a single institution.单一机构 66 例患者的分析:先天性肾和尿路异常(CAKUT)的临床表现与基因突变的相关性。
Pediatr Nephrol. 2019 Aug;34(8):1457-1464. doi: 10.1007/s00467-019-04230-w. Epub 2019 Apr 1.
6
Incidence and outcomes of kidney replacement therapy for end-stage kidney disease due to primary glomerular disease in Europe: findings from the ERA Registry.原发性肾小球疾病导致的终末期肾病在欧洲进行肾脏替代治疗的发生率和结局:来自 ERA 登记处的研究结果。
Nephrol Dial Transplant. 2024 Aug 30;39(9):1449-1460. doi: 10.1093/ndt/gfae034.
7
Epidemiology and disease burden of pediatric congenital anomalies of the kidney and urinary tract: a national cross-sectional study of hospitalized children in China.中国儿童先天性肾和尿路畸形的流行病学及疾病负担:一项针对住院儿童的全国性横断面研究
World J Pediatr. 2025 Mar;21(3):306-321. doi: 10.1007/s12519-025-00891-w. Epub 2025 Mar 25.
8
Prospective Study on Several Urinary Biomarkers as Indicators of Renal Damage in Children with CAKUT.以多种尿液生物标志物作为先天性肾脏和尿路畸形(CAKUT)患儿肾损伤指标的前瞻性研究
Eur J Pediatr Surg. 2019 Apr;29(2):215-222. doi: 10.1055/s-0038-1646960. Epub 2018 May 4.
9
Glomerular disease patients have higher odds not to reach quality targets in chronic dialysis compared with CAKUT patients: analyses from a nationwide German paediatric dialysis registry.与 CAKUT 患者相比,肾小球疾病患者在慢性透析中达到质量目标的可能性更低:来自全国性德国儿科透析登记处的分析。
Pediatr Nephrol. 2019 Jul;34(7):1229-1236. doi: 10.1007/s00467-019-04218-6. Epub 2019 Mar 6.
10
Vesicoureteral Reflux in Transplanted Kidney Among Children With Congenital Anomalies of Kidney and Urinary Tract: Case-Control Study Assessing Impact on Renal Function and Graft Survival.先天性肾脏和尿路异常儿童肾移植受者的膀胱输尿管反流:评估对肾功能和移植肾存活影响的病例对照研究
Pediatr Transplant. 2025 Feb;29(1):e70017. doi: 10.1111/petr.70017.

引用本文的文献

1
Early identification of CKD in patients with solitary functioning kidney.对单肾功能患者慢性肾脏病的早期识别。
Nephrol Dial Transplant. 2025 Jun 30;40(7):1439-1441. doi: 10.1093/ndt/gfaf063.
2
When should the nephrologist think about genetics in patients with glomerular diseases?肾脏病医生应该在什么时候考虑肾小球疾病患者的遗传学因素?
Clin Kidney J. 2025 Feb 13;18(3):sfaf044. doi: 10.1093/ckj/sfaf044. eCollection 2025 Mar.
3
Pediatric Chronic Kidney Disease During Pandemic Conditions-A Single-Center Experience.大流行期间的小儿慢性肾脏病——单中心经验

本文引用的文献

1
The genetics and pathogenesis of CAKUT.CAKUT 的遗传学和发病机制。
Nat Rev Nephrol. 2023 Nov;19(11):709-720. doi: 10.1038/s41581-023-00742-9. Epub 2023 Jul 31.
2
Inhibiting APOL1 to Treat Kidney Disease.抑制载脂蛋白L1治疗肾脏疾病。
N Engl J Med. 2023 Mar 16;388(11):1045-1049. doi: 10.1056/NEJMe2208455.
3
Inaxaplin for Proteinuric Kidney Disease in Persons with Two Variants.Inaxaplin 用于伴有两种变异的蛋白尿性肾病患者。
J Clin Med. 2025 Feb 27;14(5):1608. doi: 10.3390/jcm14051608.
N Engl J Med. 2023 Mar 16;388(11):969-979. doi: 10.1056/NEJMoa2202396.
4
Long-term multisystemic efficacy of migalastat on Fabry-associated clinical events, including renal, cardiac and cerebrovascular outcomes.麦格司他治疗 Fabry 相关临床事件(包括肾脏、心脏和脑血管结局)的长期多系统疗效。
J Med Genet. 2023 Jul;60(7):722-731. doi: 10.1136/jmg-2022-108669. Epub 2022 Dec 21.
5
Isolated kidney transplantation under lumasiran therapy in primary hyperoxaluria type 1: a report of five cases.鲁马西拉治疗下的1型原发性高草酸尿症孤立肾移植:5例报告
Nephrol Dial Transplant. 2023 Feb 13;38(2):517-521. doi: 10.1093/ndt/gfac295.
6
Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial.用于 1 型原发性高草酸尿症的卢马昔兰:III 期 ILLUMINATE-C 试验。
Am J Kidney Dis. 2023 Feb;81(2):145-155.e1. doi: 10.1053/j.ajkd.2022.05.012. Epub 2022 Jul 14.
7
The ERA Registry Annual Report 2019: summary and age comparisons.《2019年ERA注册机构年度报告:总结与年龄比较》
Clin Kidney J. 2021 Dec 15;15(3):452-472. doi: 10.1093/ckj/sfab273. eCollection 2022 Mar.
8
An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International.托伐普坦治疗常染色体显性遗传性多囊肾病的应用进展:代表欧洲肾脏协会遗传性肾脏疾病工作组、欧洲罕见肾脏疾病参考网络和多囊肾病国际组织的共识声明。
Nephrol Dial Transplant. 2022 Apr 25;37(5):825-839. doi: 10.1093/ndt/gfab312.
9
Guidelines for Genetic Testing and Management of Alport Syndrome.《Alport 综合征的基因检测与管理指南》。
Clin J Am Soc Nephrol. 2022 Jan;17(1):143-154. doi: 10.2215/CJN.04230321. Epub 2021 Dec 20.
10
Multidisciplinary approaches for elucidating genetics and molecular pathogenesis of urinary tract malformations.多学科方法阐明尿路畸形的遗传学和分子发病机制。
Kidney Int. 2022 Mar;101(3):473-484. doi: 10.1016/j.kint.2021.09.034. Epub 2021 Nov 12.